![]() Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | |||
Founding Date | Founding Date 2003 | Founding Date 2022 | Founding Date 2007 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations HQ | Locations Ramat Gan, IL HQ New York, US | Locations Fremont, US HQ Waltham, US Waltham, US |
Employees | Employees N/A | Employees 479% increase | Employees 882% increase |
Valuation ($) | Valuation ($) 16.2 m | Valuation ($) N/A | Valuation ($) 1.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $407.3m (FY, 2025) |
Cost of goods | Cost of goods kr7.2m (FY, 2025) | Cost of goods N/A | Cost of goods $39.5m (FY, 2025) |
Gross profit | Gross profit (kr6.3m) (FY, 2025) | Gross profit N/A | Gross profit $367.8m (FY, 2025) |
Net income | Net income (kr56.1m) (FY, 2025) | Net income N/A | Net income ($61.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 10m | Total funding raised $ 61.1m |
Remepy (also knwon as Remepy Health) is a company that develops hybrid drugs.
View company
Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
View company